BMJ, doi: 10.1136/bmj.38883.479549.2F, (Published 13 July 2006)

RESEARCH

Spironolactone and risk of upper gastrointestinal events: population based case-control study

Katia Verhamme ^1*, Georgio Mosis ¹, Jeanne Dieleman ¹, Bruno Stricker ², Miriam Sturkenboom ¹

¹ Department of Medical Informatics, Erasmus MC, PO Box 1738, 3000 Rotterdam, Netherlands
² Department of Epidemiology and Biostatistics, Erasmus MC

^* Correspondence to: k.verhamme{at}erasmusmc.nl.

Objective To confirm and quantify any association between spironolactone and upper gastrointestinal bleeding and ulcers.

Design Population based case-control study.

Setting A primary care information database in the Netherlands.

Participants All people on the database who were aged 18 or more between 1 January 1996 and 30 September 2003. Patients with a history of alcoholism or gastrointestinal cancer were excluded. Ten controls were matched to each case of gastroduodenal ulcer or upper gastrointestinal bleeding by age (year of birth), sex, and index date.

Main outcome measures The occurrence of an upper gastrointestinal event (bleeding or ulcers), adjusted for potential confounders with conditional logistic regression analysis.

Results Within the source population of 306 645 patients, 523 cases of gastric or duodenal ulcer or upper gastrointestinal bleeding were identified and matched to 5230 controls. Current use of spironolactone was associated with a 2.7-fold (95% confidence interval 1.2 to 6.0) increased risk of a gastrointestinal event.

Conclusion The risk of gastroduodenal ulcers or upper gastrointestinal bleeding is significantly increased in patients using spironolactone.

---

(Accepted 26 May 2006)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Spironolactone and risk of upper gastrointestinal events: Spironolactone may not be guilty

Eugene Campbell, Anthony Shonde, and Stephen Foley
BMJ 2006 333: 500. [Extract] [Full Text]

Spironolactone and risk of upper gastrointestinal events: Association is unproved

Muhammad F Dawwas
BMJ 2006 333: 501. [Extract] [Full Text]

Spironolactone and risk of upper gastrointestinal events: Causality remains unconvincing

Gruffydd P Jones
BMJ 2006 333: 501. [Extract] [Full Text]

Spironolactone is associated with upper GI events
BMJ 2006 333: 0. [Full Text]

Diminishing returns

Fiona Godlee
BMJ 2006 333: 0. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Dawwas, M. F (2006). Spironolactone and risk of upper gastrointestinal events: Association is unproved.. BMJ 333: 501-501 [Full text]  
• Campbell, E., Shonde, A., Foley, S. (2006). Spironolactone and risk of upper gastrointestinal events: Spironolactone may not be guilty.. BMJ 333: 500-500 [Full text]  
• Jones, G. P (2006). Spironolactone and risk of upper gastrointestinal events: Causality remains unconvincing.. BMJ 333: 501-501 [Full text]  

Rapid Responses:

Read all Rapid Responses

Helicobacter pylori and spironolactone -the duo may be more ulcerogenic?

Prasanta Padhan
bmj.com, 14 Jul 2006 [Full text]

Spironolactone and risk of upper gastrointestinal events

Asif Raheem, et al.
bmj.com, 16 Jul 2006 [Full text]

Spironolactone and upper G.I. events

Mohan P Thottatthil
bmj.com, 16 Jul 2006 [Full text]

Does spironolactone cause a fall in intramucosal pH?

Richard G Fiddian-Green
bmj.com, 17 Jul 2006 [Full text]

Spironolactone may not be guilty

Eugene Campbell, et al.
bmj.com, 21 Jul 2006 [Full text]

Spironolactone and risk of upper gastrointestinal events: population based case-control study

Tilak Ghosh
bmj.com, 24 Jul 2006 [Full text]

Author's reply

Katia M Verhamme, et al.
bmj.com, 9 Aug 2006 [Full text]

Spironolactone and risk of upper gastrointestinal events: cause or effect?

Neeraj Bhala, et al.
bmj.com, 12 Aug 2006 [Full text]

Spironolactone and risk of upper gastrointestinal events: comments

Jennifer E Stark
bmj.com, 12 Aug 2006 [Full text]

Causality schmausality

Gruffydd P Jones
bmj.com, 12 Aug 2006 [Full text]

Spironolactone : Causality of upper gastrointestinal events is not proven

Shui Hao Chin, et al.
bmj.com, 16 Aug 2006 [Full text]

Spironolactone and liver cirrhosis

Mario Guslandi
bmj.com, 17 Aug 2006 [Full text]

Spironolactone and increased risk of upper gastrointestinal bleeding: an unproven association

Muhammad F Dawwas
bmj.com, 17 Aug 2006 [Full text]

Spironolactone's role is undiminished.

Edoardo Cervoni
bmj.com, 17 Aug 2006 [Full text]

Ulcerogenic medications and H. Pylori are the cause of peptic ulcer.

Nicholas I Church
bmj.com, 27 Aug 2006 [Full text]

Spironolactone in heart failure-severity does matter.

vinod aiyappan
bmj.com, 18 Sep 2006 [Full text]